Fate Therapeutics to Participate in Upcoming Conferences

Fate Therapeutics, Inc. will participate in upcoming conferences during the fourth quarter of 2026. The company is a clinical-stage biopharmaceutical firm focused on cellular immunotherapies for cancer and autoimmune diseases.